Etiology, ischemic or not, of the initial transient visual disturbance 3 months [clinicaltrials_resource:17b1b35085eec03eb5608a82143661c3]
Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Etiology, ischemic or not, of the initial transient visual disturbance 3 months [clinicaltrials_resource:17b1b35085eec03eb5608a82143661c3]
Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.
Bio2RDF identifier
17b1b35085eec03eb5608a82143661c3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:17b1b35085eec03eb5608a82143661c3
measure [clinicaltrials_vocabulary:measure]
Etiology, ischemic or not, of the initial transient visual disturbance
time frame [clinicaltrials_vocabulary:time-frame]
description
Clinical : questionnaire about ...... new evaluation after 3 months.
identifier
clinicaltrials_resource:17b1b35085eec03eb5608a82143661c3
title
Etiology, ischemic or not, of the initial transient visual disturbance 3 months
@en
type
label
Etiology, ischemic or not, of ...... 1b35085eec03eb5608a82143661c3]
@en